Request for Covid-19 Impact Assessment of this Report

Medical Devices

Life Science Analytics Software Market by Product (Descriptive Analytics, Prescriptive Analytics, and Predictive Analytics), Application (Research & Development, Sales & ing Support, Regulatory Compliance, Supply Chain Analytics, and Pharmacovigilance), Delivery Model (On-Premise and Cloud), and End User (Pharmaceutical & Biotechnology Companies, Medical Device Companies, Research Centers and Third-Party Administrators): Global Opportunity Analysis and Industry Forecast, 2020-2027

  • ALL3907869
  • 289 Pages
  • June 2020
  • Medical Devices
Download Sample    Get Discount   
 
The global life science analytics software market size in 2019 was $5.35 billion in 2019, and is expected to reach $16.04 billion by 2027 at a CAGR of 12.3% from 2020 to 2027.The life sciences industry is moving from treatment to preventive scenarios and management of patient's health outcomes. In addition, early detection of disease patterns and strategic target is the key for effective business strategies. Thus, life science companies are demanding for analytics software that is used to transform data into useful insights. In addition, benefits of analytics software in life sciences such as early detection of prescription and treatment patterns, strategizing patient outcomes and achieving better operational quality that drives the intellectual journey of patient centricity further boosts the growth of the global life science analytics software market.

The market is derived completely on the basis of the revenue generated through software license, subscription and maintenance. These are used in research & development, clinical trials, preclinical trials, sales & marketing support, regulatory compliance, supply chain analytics and pharmacovigilance. The major factors driving the growth of the life science analytics software is rise in in prevalence of chronic disease; and pressure to reduce healthcare expenditure and increased demand for improved patient outcomes. In addition, increase in adoption of analytics solutions in clinical trials and sales & marketing applications further boosts the market growth. However, lack of skilled professionals in developing countries and data privacy issues hamper the market growth. On the contrary, emergence of big data analytics to increase R&D productivity is anticipated to provide significant profitable opportunities for manufacturers in the life science analytics software industry.

The life science analytics software market is segmented on the basis of product, application, delivery model, end user and region. By product, it is divided into descriptive analytics, prescriptive analytics and predictive analytics. On the basis of application, it is classified into research & development, sales & marketing support, regulatory compliance, supply chain analytics and pharmacovigilance. The research & development is further segmented into clinical trials and preclinical trials. On the basis of delivery model, it is bifurcated into on-premise and cloud. By end user, it is segmented into pharmaceutical & biotechnology companies, medical device companies, research centers and third-party administrators (TPAS). Region wise, the market is analyzed across North America, Europe, Asia-Pacific and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

 This report entails a detailed quantitative analysis along with the current global life science analytics software market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessment

 The market forecast is studied from 2020 to 2027

 The market size and estimations are based on a comprehensive analysis of key developments in the industry

 A qualitative analysis based on innovative products facilitates strategic business planning.

 The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

KEY MARKET SEGMENTS

By Product

• Descriptive Analytics

• Predictive Analytics

• Prescriptive Analytics

By Application

• Research and Development

o Clinical Trials

o Preclinical Trials

• Sales and Marketing Support

• Regulatory Compliance

• Supply Chain Analytics

• Pharmacovigilance

By Delivery

• On-Premise

• Clouds

By End User

• Pharmaceutical and Biotechnology Companies

• Medical Device Companies

• Research Centers

• Third Party Administrators (TPAS)

By Region

• North America

o U.S.

o Canada

o Mexico

• Europe

o Germany

o France

o UK

o Italy

o Spain

o Rest of Europe

KEY MARKET PLAYERS

• Accenture Plc,

• ArisGlobal LLC,

• Chemical Abstracts Services (ACS)

• Certara, L.P

• Clarivate Analytics Plc.

• Cognizant Technology Solutions Corporation

• Dassault Systemes

• Deloitte Touche Tohmatsu Limited.

• IQVIA Holdings Inc

• Microsoft Corporation

• Oracle Corporation

• TIBCO Software Inc.

• Veeva Systems Inc.

The other players in the value chain include (profiles not included in the report):

• IBM Corporation

• Quintiles Inc

• SAS Institute Inc.

• SCIO Health Analytics

• TAKE Solutions

CHAPTER 1:INTRODUCTION

1.1.Report description

1.2.Key benefits for stakeholders

1.3.Key market segments

1.4.Research methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

1.4.4.Primary research

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.2.2.Top winning strategies

3.2.3.Top player positioning, 2019

3.3.Porter’s five forces analysis

3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Surge in prevalence of chronic disease

3.4.1.2.Pressure to reduce healthcare expenditure & increased demand for improved patient outcomes.

3.4.1.3.Rise in adoption of analytics solutions in clinical trials and sales & marketing applications

3.4.2.Restraints

3.4.2.1.Lack of skilled professionals in developing countries

3.4.2.2.Data privacy issues

3.4.3.Opportunity

3.4.3.1.Emergence of big data analytics to increase R&D productivity

CHAPTER 4:GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Descriptive analytics

4.2.1.Key market trends, growth factors and opportunities

4.2.2.Market size and forecast, by region

4.2.3.Market analysis, by country

4.3.Predictive Analytics

4.3.1.Key market trends, growth factors and opportunities

4.3.2.Market size and forecast, by region

4.3.3.Market analysis, by country

4.4.Prescriptive analytics

4.4.1.Key market trends, growth factors and opportunities

4.4.2.Market size and forecast, by region

4.4.3.Market analysis, by country

CHAPTER 5:GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Research and development

5.2.1.Market size and forecast, by type

5.2.1.1.Clinical Trials

5.2.1.1.1.Market size and forecast

5.2.1.2.Preclinical Trials

5.2.1.2.1.Market size and forecast

5.2.2.Market size and forecast, by region

5.2.3.Market analysis, by country

5.3.Sales and marketing support

5.3.1.Market size and forecast, by region

5.3.2.Market analysis, by country

5.4.Regulatory compliance

5.4.1.Market size and forecast, by region

5.4.2.Market analysis, by country

5.5.Supply chain analytics

5.5.1.Market size and forecast, by region

5.5.2.Market analysis, by country

5.6.Pharmacovigilance

5.6.1.Market size and forecast, by region

5.6.2.Market analysis, by country

CHAPTER 6:GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL

6.1.Overview

6.1.1.Market size and forecast

6.2.On-premise

6.2.1.Market size and forecast, by region

6.2.2.Market analysis, by country

6.3.Cloud

6.3.1.Market size and forecast, by region

6.3.2.Market analysis, by country

CHAPTER 7:GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET BY END USER

7.1.Overview

7.1.1.Market size and forecast

7.2.Pharmaceutical and biotechnology companies

7.2.1.Market size and forecast, by region

7.2.2.Market analysis, by country

7.3.Medical device companies

7.3.1.Market size and forecast, by region

7.3.2.Market analysis, by country

7.4.Research centers

7.4.1.Market size and forecast, by region

7.4.2.Market analysis, by country

7.5.Third-party administrators

7.5.1.Market size and forecast, by region

7.5.2.Market analysis, by country

CHAPTER 8:LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY REGION

8.1.Overview

8.1.1.Market size and forecast

8.2.North America

8.2.1.Key market trends, growth factors and opportunities

8.2.2.North America life science analytics software market, by country

8.2.2.1.U.S. life science analytics software market, by product

8.2.2.2.U.S life science analytics software market, by application

8.2.2.3.U.S. life science analytics software market, by delivery model

8.2.2.4.U.S. life science analytics software market, by end user

8.2.2.5.Canada life science analytics software market, by product

8.2.2.6.Canada life science analytics software market, by application

8.2.2.7.Canada life science analytics software market, by delivery model

8.2.2.8.Canada life science analytics software market, by end user

8.2.2.9.Mexico life science analytics software market, by product

8.2.2.10.Mexico life science analytics software market, by application

8.2.2.11.Mexico life science analytics software market, by delivery model

8.2.2.12.Mexico life science analytics software market, by end user

8.2.3.North America life science analytics software market, by product

8.2.4.North America life science analytics software market, by application

8.2.5.North America life science analytics software market, by delivery model

8.2.6.North America life science analytics software market, by end user

8.3.Europe

8.3.1.Key market trends, growth factors and opportunities

8.3.2.Europe life science analytics software market, by country

8.3.2.1.UK life science analytics software market, by product

8.3.2.2.UK life science analytics software market, by application

8.3.2.3.UK life science analytics software market, by delivery model

8.3.2.4.UK life science analytics software market, by end user

8.3.2.5.Germany life science analytics software market, by product

8.3.2.6.Germany life science analytics software market, by application

8.3.2.7.Germany life science analytics software market, by delivery model

8.3.2.8.Germany life science analytics software market, by end user

8.3.2.9.France life science analytics software market, by product

8.3.2.10.France life science analytics software market, by application

8.3.2.11.France life science analytics software market, by delivery model

8.3.2.12.France life science analytics software market, by end user

8.3.2.13.Italy life science analytics software market, by product

8.3.2.14.Italy life science analytics software market, by application

8.3.2.15.Italy life science analytics software market, by delivery model

8.3.2.16.Italy life science analytics software market, by end user

8.3.2.17.Spain life science analytics software market, by product

8.3.2.18.Spain life science analytics software market, by application

8.3.2.19.Spain life science analytics software market, by delivery model

8.3.2.20.Spain life science analytics software market, by end user

8.3.2.21.Rest of Europe life science analytics software market, by product

8.3.2.22.Rest of Europe life science analytics software market, by application

8.3.2.23.Rest of Europe life science analytics software market, by delivery model

8.3.2.24.Rest of Europe life science analytics software market, by end user

8.3.3.Europe life science analytics software market, by product

8.3.4.Europe life science analytics software market, by application

8.3.5.Europe life science analytics software market, by delivery model

8.3.6.Europe life science analytics software market, by end user

8.4.Asia-pacific

8.4.1.Key market trends, growth factors and opportunities

8.4.2.Asia-Pacific life science analytics software market, by country

8.4.2.1.Japan life science analytics software market, by product

8.4.2.2.Japan life science analytics software market, by application

8.4.2.3.Japan life science analytics software market, by delivery model

8.4.2.4.Japan life science analytics software market, by end user

8.4.2.5.China life science analytics software market, by product

8.4.2.6.China life science analytics software market, by application

8.4.2.7.China life science analytics software market, by delivery model

8.4.2.8.China life science analytics software market, by end user

8.4.2.9.Australia life science analytics software market, by product

8.4.2.10.Australia life science analytics software market, by application

8.4.2.11.Australia life science analytics software market, by delivery model.

8.4.2.12.Australia life science analytics software market, by end user

8.4.2.13.India life science analytics software market, by product

8.4.2.14.India life science analytics software market, by application

8.4.2.15.India life science analytics software market, by delivery model

8.4.2.16.India life science analytics software market, by end user

8.4.2.17.Rest of Asia-Pacific life science analytics software market, by product

8.4.2.18.Rest of Asia-Pacific life science analytics software market, by application

8.4.2.19.Rest of Asia-Pacific life science analytics software market, by delivery model

8.4.2.20.Rest of Asia-Pacific life science analytics software market, by end user

8.4.3.Asia-Pacific life science analytics software market, by product

8.4.4.Asia-Pacific life science analytics software market, by application

8.4.5.Asia-Pacific life science analytics software market, by delivery model

8.4.6.Asia-Pacific life science analytics software market, by end user

8.5.LAMEA

8.5.1.Key market trends, growth factors and opportunities

8.5.2.LAMEA life science analytics software market, by country

8.5.2.1.Brazil life science analytics software market, by product

8.5.2.2.Brazil life science analytics software market, by application

8.5.2.3.Brazil life science analytics software market, by delivery model

8.5.2.4.Brazil life science analytics software market, by end user

8.5.2.5.Saudi Arabia life science analytics software market, by product

8.5.2.6.Saudi Arabia life science analytics software market, by application

8.5.2.7.Saudi Arabia life science analytics software market, by delivery model

8.5.2.8.Saudi Arabia life science analytics software market, by end user

8.5.2.9.South Africa life science analytics software market, by product

8.5.2.10.South Africa life science analytics software market, by application

8.5.2.11.South Africa life science analytics software market, by delivery model

8.5.2.12.South Africa life science analytics software market, by end user

8.5.2.13.Rest of LAMEA life science analytics software market, by product

8.5.2.14.Rest of LAMEA life science analytics software market, by application

8.5.2.15.Rest of LAMEA life science analytics software market, by delivery model

8.5.2.16.Rest of LAMEA life science analytics software market, by end user

8.5.3.LAMEA life science analytics software market, by product

8.5.4.LAMEA life science analytics software market, by application

8.5.5.LAMEA life science analytics software market, by delivery model

8.5.6.LAMEA life science analytics software market, by end user

CHAPTER 9:COMPANY PROFILES

9.1.ACCENTURE PLC

9.1.1.Company overview

9.1.2.Company snapshot

9.1.3.Operating business segments

9.1.4.Product portfolio

9.1.5.Business performance

9.2.ARISGLOBAL LLC

9.2.1.Company overview

9.2.2.Company snapshot

9.2.3.Operating business segments

9.2.4.Product portfolio

9.2.5.Key strategic moves and developments

9.3.CHEMICAL ABSTRACTS SERVICES (ACS)

9.3.1.Company overview

9.3.2.Company snapshot

9.3.3.Operating business segments

9.3.4.Product portfolio

9.4.CERTARA, L.P.

9.4.1.Company overview

9.4.2.Company snapshot

9.4.3.Operating business segments

9.4.4.Product portfolio

9.4.5.Key strategic moves and developments

9.5.CLARIVATE ANALYTICS PLC

9.5.1.Company overview

9.5.2.Company snapshot

9.5.3.Operating business segments

9.5.4.Product portfolio

9.5.5.Business performance

9.5.6.Key strategic moves and developments

9.6.COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION

9.6.1.Company overview

9.6.2.Company snapshot

9.6.3.Operating business segments

9.6.4.Product portfolio

9.6.5.Business performance

9.6.6.Key strategic moves and developments

9.7.DASSAULT SYSTEMES

9.7.1.Company overview

9.7.2.Company snapshot

9.7.3.Operating business segments:

9.7.4.Product portfolio

9.7.5.Business performance

9.8.DELOITTE

9.8.1.Company overview

9.8.2.Company snapshot

9.8.3.Operating business segments

9.8.4.Product portfolio

9.8.5.Business performance

9.9.IQVIA HOLDINGS INC

9.9.1.Company overview

9.9.2.Company snapshot

9.9.3.Operating business segments

9.9.4.Product portfolio

9.9.5.Business performance

9.9.6.Key strategic moves and developments

9.10.MICROSOFT CORPORATION

9.10.1.Company overview

9.10.2.Company snapshot

9.10.3.Operating business segments

9.10.4.Product portfolio

9.10.5.Business performance

9.11.ORACLE CORPORATION

9.11.1.Company overview

9.11.2.Company snapshot

9.11.3.Operating business segments

9.11.4.Product portfolio

9.11.5.Business performance

9.11.6.Key strategic moves and developments

9.12.TIBCO SOFTWARE INC

9.12.1.Company overview

9.12.2.Operating business segments

9.12.3.Product portfolio

9.13.VEEVA SYSTEMS INC

9.13.1.Company overview

9.13.2.Company snapshot

9.13.3.Operating business segments

9.13.4.Product portfolio

9.13.5.Business performance

LIST OF TABLES

TABLE 01.LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 02.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR DESCRIPTIVE ANALYTICS, BY REGION, 2019–2027 ($MILLION)

TABLE 03.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR PREDICTIVE ANALYTICS, BY REGION, 2019–2027 ($MILLION)

TABLE 04.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FORPRESCRIPTIVE ANALYTICS, BY REGION, 2019–2027 ($MILLION)

TABLE 05.LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 06.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR RESEARCH AND DEVELOPMENT, BY TYPE, 2019–2027 ($MILLION)

TABLE 07.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR RESEARCH AND DEVELOPMENT, BY REGION, 2019–2027 ($MILLION)

TABLE 08.GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR SALES AND MARKETING SUPPORT, BY REGION, 2019–2027 ($MILLION)

TABLE 09.GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR REGULATORY COMPLIANCE, BY REGION, 2019–2027 ($MILLION)

TABLE 10.GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR SUPPLY CHAIN ANALYTICS, BY REGION, 2019–2027 ($MILLION)

TABLE 11.GLOBAL LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR PHARMACOVIGILANCE, BY REGION, 2019–2027 ($MILLION)

TABLE 12.LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027($MILLION)

TABLE 13.LIFE SCIENCE ANALYTICS SOFTWARE MARKET FOR ON-PREMISE, BY REGION, 2019–2027 ($MILLION)

TABLE 14.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR CLOUD, BY REGION, 2019–2027 ($MILLION)

TABLE 15.LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 16.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2019–2027 ($MILLION)

TABLE 17.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR MEDICAL DEVICE COMPANIES, BY REGION, 2019–2027 ($MILLION)

TABLE 18.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR RESEARCH CENTERS, BY REGION, 2019–2027 ($MILLION)

TABLE 19.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE FOR THIRD-PARTY ADMINISTRATORS, BY REGION, 2019–2027 ($MILLION)

TABLE 20.LIFE SCIENCE ANALYTICS SOFTWARE MARKET REVENUE, BY REGION, 2019–2027 ($MILLION)

TABLE 21.NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)

TABLE 22.U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 23.U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 24.U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 25.U.S. LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 26.CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 27.CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 28.CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 29.CANADA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 30.MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 31.MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 32.MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 33.MEXICO LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 34.NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 35.NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 36.NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 37.NORTH AMERICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 38.EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)

TABLE 39.UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 40.UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 41.UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 42.UK LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 43.GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 44.GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 45.GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 46.GERMANY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 47.FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 48.FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 49.FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 50.FRANCE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 51.ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 52.ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 53.ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 54.ITALY LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 55.SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 56.SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 57.SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 58.SPAIN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 59.REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 60.REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 61.REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 62.REST OF EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 63.EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 64.EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 65.EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 66.EUROPE LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 67.ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)

TABLE 68.JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 69.JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 70.JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 71.JAPAN LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 72.CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 73.CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 74.CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 75.CHINA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 76.AUSTRALIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 77.AUSTRALIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 78.AUSTRALIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 79.AUSTRALIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 80.INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 81.INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 82.INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 83.INDIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 84.REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 85.REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 86.REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 87.REST OF ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 88.ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 89.ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 90.ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 91.ASIA-PACIFIC LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 92.LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2019–2027 ($MILLION)

TABLE 93.BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 94.BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 95.BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 96.BRAZIL LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 97.SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 98.SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 99.SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 100.SAUDI ARABIA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 101.SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 102.SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 103.SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 104.SOUTH AFRICA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 105.REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 106.REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 107.REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 108.REST OF LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 109.LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY PRODUCT, 2019–2027 ($MILLION)

TABLE 110.LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY APPLICATION, 2019–2027 ($MILLION)

TABLE 111.LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY DELIVERY MODEL, 2019–2027 ($MILLION)

TABLE 112.LAMEA LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY END USER, 2019–2027 ($MILLION)

TABLE 113.ACCENTURE: COMPANY SNAPSHOT

TABLE 114.: PRODUCT SEGMENTS

TABLE 115.ACCENTURE: PRODUCT PORTFOLIO

TABLE 116.ARISGLOBAL: COMPANY SNAPSHOT

TABLE 117.ARISGLOBAL: OPERATING SEGMENTS

TABLE 118.ARISGLOBAL: PRODUCT PORTFOLIO

TABLE 119.CAS/ACS: COMPANY SNAPSHOT

TABLE 120.CAS/ACS: OPERATING SEGMENTS

TABLE 121.CAS/ACS: PRODUCT PORTFOLIO

TABLE 122.CERTARA: COMPANY SNAPSHOT

TABLE 123.CERTARA: OPERATING SEGMENTS

TABLE 124.CERTARA: PRODUCT PORTFOLIO

TABLE 125.CLARIVATE: COMPANY SNAPSHOT

TABLE 126.CLARIVATE: OPERATING BUSINESS SEGMENTS

TABLE 127.CLARIVATE: PRODUCT PORTFOLIO

TABLE 128.COGNIZANT: COMPANY SNAPSHOT

TABLE 129.COGNIZANT: OPERATING BUSINESS SEGMENTS

TABLE 130.COGNIZANT: PRODUCT PORTFOLIO

TABLE 131.DASSAULT: COMPANY SNAPSHOT

TABLE 132.DASSAULT: OPERATING BUSINESS SEGMENTS

TABLE 133.DASSAULT: PRODUCT PORTFOLIO

TABLE 134.DELOITTE: COMPANY SNAPSHOT

TABLE 135.DELOITTE: OPERATING SEGMENTS

TABLE 136.DELOITTE: PRODUCT PORTFOLIO

TABLE 137.IQVIA: COMPANY SNAPSHOT

TABLE 138.IQVIA: OPERATING SEGMENTS

TABLE 139.IQVIA: PRODUCT PORTFOLIO

TABLE 140.MICROSOFT: COMPANY SNAPSHOT

TABLE 141.MICROSOFT: OPERATING SEGMENTS

TABLE 142.MICROSOFT: PRODUCT PORTFOLIO

TABLE 143.ORACLE: COMPANY SNAPSHOT

TABLE 144.ORACLE: OPERATING SEGMENTS

TABLE 145.ORACLE: PRODUCT PORTFOLIO

TABLE 146.TIBCO: COMPANY SNAPSHOT

TABLE 147.TIBCO: OPERATING SEGMENTS

TABLE 148.TIBCO: PRODUCT PORTFOLIO

TABLE 149.VEEVA: COMPANY SNAPSHOT

TABLE 150.VEEVA: OPERATING SEGMENTS

TABLE 151.VEEVA: PRODUCT PORTFOLIO

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370